ATXI Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | Fortress Biotech, Inc. | 10 percent owner | 561,561 | A-Award | A | 231,316 | 0.00 | 0.00 |
| 2022-12-31 | Fortress Biotech, Inc. | 10 percent owner | 330,245 | A-Award | A | 90,909 | 0.00 | 0.00 |
| 2022-10-11 | InvaGen Pharmaceuticals, Inc. | 10 percent owner | 0 | S-Sale | D | 388,888 | 7.71 | 2,999,882.03 |
| 2021-12-17 | Herskowitz Neil | director | 183,744 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2021-12-17 | Herskowitz Neil | director | 163,744 | A-Award | A | 49,020 | 0.00 | 0.00 |
| 2021-12-17 | Oltmans Curtis Gale | director | 49,020 | A-Award | A | 49,020 | 0.00 | 0.00 |
| 2021-12-17 | KRANZLER JAY D | director | 133,683 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2021-12-17 | KRANZLER JAY D | director | 113,683 | A-Award | A | 49,020 | 0.00 | 0.00 |
| 2021-12-17 | Vazzano Joseph Walter | officer: Chief Financial Officer | 165,757 | A-Award | A | 100,505 | 0.00 | 0.00 |
| 2021-12-17 | Lu Lucy | director, officer: President, CEO | 748,949 | A-Award | A | 411,616 | 0.00 | 0.00 |
| 2021-09-15 | Vazzano Joseph Walter | officer: Chief Financial Officer | 65,252 | S-Sale | D | 7,160 | 1.62 | 11,599.20 |
| 2021-05-06 | Herskowitz Neil | director | 134,724 | P-Purchase | A | 2,500 | 3.99 | 9,975.00 |
| 2020-08-20 | Vazzano Joseph Walter | officer: Chief Financial Officer | 57,412 | S-Sale | D | 3,840 | 12.13 | 46,579.20 |
| 2020-06-16 | Herskowitz Neil | director | 132,224 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2020-06-16 | KRANZLER JAY D | director | 84,663 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2020-03-10 | Vazzano Joseph Walter | officer: Chief Financial Officer | 61,252 | P-Purchase | A | 1,889 | 7.94 | 14,998.66 |
| 2020-03-09 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,263 | P-Purchase | A | 1,400 | 7.99 | 11,186.00 |
| 2020-03-09 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,363 | P-Purchase | A | 100 | 7.97 | 797.00 |
| 2020-02-27 | Herskowitz Neil | director | 122,224 | P-Purchase | A | 2,400 | 8.20 | 19,680.00 |
| 2020-02-26 | Herskowitz Neil | director | 119,824 | P-Purchase | A | 161 | 8.73 | 1,405.53 |
| 2020-02-25 | Vazzano Joseph Walter | officer: Chief Financial Officer | 57,863 | P-Purchase | A | 1,200 | 9.09 | 10,908.00 |
| 2020-02-25 | Herskowitz Neil | director | 119,663 | P-Purchase | A | 10,000 | 9.31 | 93,100.00 |
| 2020-02-12 | Vazzano Joseph Walter | officer: Chief Financial Officer | 50,505 | A-Award | A | 22,727 | 0.00 | 0.00 |
| 2020-02-12 | Lu Lucy | director, officer: President, CEO | 246,576 | A-Award | A | 110,959 | 0.00 | 0.00 |
| 2019-09-12 | Ingram Elizabeth Garrett | director | 16,000 | P-Purchase | A | 16,000 | 0.00 | 0.00 |
| 2019-08-27 | Herskowitz Neil | director | 109,663 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2019-08-27 | KRANZLER JAY D | director | 74,663 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2019-08-09 | Vazzano Joseph Walter | officer: Chief Financial Officer | 56,663 | S-Sale | D | 2,375 | 0.00 | 0.00 |
| 2019-08-08 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,038 | S-Sale | D | 2,313 | 0.00 | 0.00 |
| 2019-06-18 | Herskowitz Neil | director | 99,663 | P-Purchase | A | 2,000 | 0.00 | 0.00 |
| 2019-06-17 | Herskowitz Neil | director | 97,663 | P-Purchase | A | 3,000 | 0.00 | 0.00 |
| 2019-06-03 | Vazzano Joseph Walter | officer: Chief Financial Officer | 27,778 | A-Award | A | 27,778 | 0.00 | 0.00 |
| 2019-06-03 | Lu Lucy | director, officer: President, CEO | 135,617 | A-Award | A | 135,617 | 0.00 | 0.00 |
| 2019-04-15 | Herskowitz Neil | director | 94,663 | P-Purchase | A | 1,000 | 4.52 | 4,520.00 |
| 2019-03-29 | Herskowitz Neil | director | 93,663 | P-Purchase | A | 1,400 | 5.11 | 7,154.00 |
| 2019-03-28 | Herskowitz Neil | director | 92,263 | P-Purchase | A | 600 | 5.11 | 3,066.00 |
| 2019-02-25 | Herskowitz Neil | director | 91,663 | P-Purchase | A | 5,000 | 0.00 | 0.00 |
| 2019-02-05 | Herskowitz Neil | director | 86,663 | P-Purchase | A | 1,850 | 5.77 | 10,674.50 |
| 2019-02-04 | Herskowitz Neil | director | 84,813 | P-Purchase | A | 7,000 | 5.91 | 41,370.00 |
| 2019-01-30 | Herskowitz Neil | director | 77,813 | P-Purchase | A | 650 | 5.91 | 3,841.50 |
| 2019-01-29 | Herskowitz Neil | director | 77,163 | P-Purchase | A | 8,553 | 5.91 | 50,548.23 |
| 2019-01-28 | Herskowitz Neil | director | 68,610 | P-Purchase | A | 1,447 | 5.84 | 8,450.48 |
| 2018-12-10 | Paley Jeffrey | director | 79,663 | P-Purchase | A | 5,000 | 4.76 | 23,800.00 |
| 2018-12-03 | Paley Jeffrey | director | 74,663 | P-Purchase | A | 10,000 | 5.48 | 54,754.00 |
| 2018-08-07 | Reines Scott | officer: Interim Chief Medical Officer | 45,000 | G-Gift | A | 10,000 | 0.00 | 0.00 |
| 2018-08-07 | SAMAD AKHTAR | director | 64,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | Herskowitz Neil | director | 67,163 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | ROSENWALD LINDSAY A MD | director | 84,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | Vazzano Joseph Walter | officer: Chief Financial Officer | 61,351 | G-Gift | A | 30,000 | 0.00 | 0.00 |
| 2018-08-07 | Lu Lucy | director, officer: President, CEO | 807,333 | G-Gift | A | 250,000 | 0.00 | 0.00 |
| 2018-08-07 | Paley Jeffrey | director | 64,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | WEISS MICHAEL S | director | 24,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-08-07 | KRANZLER JAY D | director | 64,663 | G-Gift | A | 14,663 | 0.00 | 0.00 |
| 2018-06-28 | Vazzano Joseph Walter | officer: Chief Financial Officer | 31,351 | A-Award | A | 1,351 | 3.66 | 4,944.66 |
| 2018-06-14 | Lu Lucy | director, officer: President, CEO | 557,333 | A-Award | A | 5,000 | 4.00 | 20,000.00 |
| 2018-06-08 | ROSENWALD LINDSAY A MD | director | 70,000 | P-Purchase | A | 5,234 | 4.34 | 22,726.55 |
| 2018-06-08 | ROSENWALD LINDSAY A MD | director | 25,234 | P-Purchase | A | 5,234 | 4.34 | 22,715.56 |
| 2018-06-07 | ROSENWALD LINDSAY A MD | director | 64,766 | P-Purchase | A | 14,800 | 4.32 | 63,968.56 |
| 2018-06-06 | ROSENWALD LINDSAY A MD | director | 49,966 | P-Purchase | A | 9,100 | 4.35 | 39,575.90 |
| 2018-06-05 | ROSENWALD LINDSAY A MD | director | 40,866 | P-Purchase | A | 8,400 | 4.28 | 35,948.64 |
| 2018-06-04 | ROSENWALD LINDSAY A MD | director | 32,466 | P-Purchase | A | 3,800 | 4.19 | 15,920.86 |
| 2018-06-01 | ROSENWALD LINDSAY A MD | director | 28,666 | P-Purchase | A | 8,666 | 4.15 | 36,002.90 |
| 2018-04-25 | Herskowitz Neil | director | 52,500 | P-Purchase | A | 1,000 | 3.80 | 3,800.00 |
| 2017-10-17 | Herskowitz Neil | director | 51,500 | P-Purchase | A | 1,000 | 5.01 | 5,010.00 |
| 2017-10-09 | ROSENWALD LINDSAY A MD | director | 20,000 | P-Purchase | A | 1,350 | 0.00 | 0.00 |
| 2017-10-09 | Herskowitz Neil | director | 50,500 | P-Purchase | A | 500 | 5.24 | 2,620.00 |
| 2017-10-06 | ROSENWALD LINDSAY A MD | director | 18,650 | P-Purchase | A | 2,900 | 0.00 | 0.00 |
| 2017-10-05 | ROSENWALD LINDSAY A MD | director | 15,750 | P-Purchase | A | 3,550 | 0.00 | 0.00 |
| 2017-10-04 | ROSENWALD LINDSAY A MD | director | 12,200 | P-Purchase | A | 2,200 | 0.00 | 0.00 |
| 2017-09-28 | Lu Lucy | director, officer: President, CEO | 552,333 | A-Award | A | 4,000 | 5.20 | 20,800.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.